PriceTargets.com logo

NextGen Healthcare - NXGN Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $22.75
  • Forecasted Upside: 32.89%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$17.12 As of 03/30/2023 01:00 AM ET
▼ -0.2 (-1.15%)

This chart shows the closing price for NXGN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NextGen Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NXGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NXGN

Analyst Price Target is $22.75
▲ +32.89% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for NextGen Healthcare in the last 3 months. The average price target is $22.75, with a high forecast of $26.00 and a low forecast of $20.00. The average price target represents a 32.89% upside from the last price of $17.12.

This chart shows the closing price for NXGN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in NextGen Healthcare. This rating has held steady since April 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
10/6/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
1/4/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
4/4/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/3/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/1/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/30/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/26/2022SVB LeerinkBoost TargetOutperform$24.00 ➝ $25.00Low
10/21/2022Piper SandlerReiterated RatingNeutral$20.00Low
9/7/2022Truist FinancialInitiated CoverageHold$20.00Low
5/6/2022GuggenheimUpgradeNeutral ➝ Buy$26.00Medium
4/13/2022GuggenheimInitiated CoverageNeutralHigh
1/26/2022Piper SandlerBoost Target$23.00 ➝ $24.00Medium
1/6/2022SVB LeerinkUpgradeMarket Perform ➝ Outperform$22.00High
7/30/2021Colliers SecuritiesReiterated RatingBuy$21.00Low
7/30/2021Royal Bank of CanadaLower TargetSector Perform$21.00 ➝ $19.00High
6/24/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
5/27/2021Piper SandlerReiterated RatingOverweight$24.00 ➝ $23.00High
4/29/2021JPMorgan Chase & Co.Initiated CoverageUnderweightMedium
2/19/2021Cantor FitzgeraldUpgradeNeutral ➝ Overweight$20.00 ➝ $23.00High
2/16/2021Piper SandlerBoost TargetOverweight$22.00 ➝ $24.00Low
1/28/2021Piper SandlerBoost TargetOverweight$21.00 ➝ $22.00High
1/28/2021SVB LeerinkBoost TargetMarket Perform$21.00 ➝ $22.00Low
1/28/2021Morgan StanleyBoost TargetUnderweight$14.00 ➝ $18.00High
1/28/2021Deutsche Bank AktiengesellschaftBoost TargetHold$13.00 ➝ $19.00High
1/14/2021Royal Bank of CanadaBoost TargetSector Perform ➝ Positive$14.00 ➝ $21.00High
12/11/2020Colliers SecuritiesReiterated RatingBuyHigh
10/26/2020Morgan StanleyBoost TargetUnderweight$12.00 ➝ $14.00High
10/23/2020SVB LeerinkBoost TargetMarket Perform$12.00 ➝ $14.00High
10/23/2020Cantor FitzgeraldBoost TargetNeutral$13.00 ➝ $15.00High
10/23/2020Piper SandlerLower TargetOverweight$23.00 ➝ $21.00High
8/11/2020Morgan StanleyBoost TargetUnderweight$8.00 ➝ $12.00Medium
8/3/2020Deutsche Bank AktiengesellschaftBoost TargetHold$9.00 ➝ $13.00Medium
7/31/2020Wells Fargo & CompanyReiterated RatingHoldLow
7/31/2020Cantor FitzgeraldBoost TargetNeutral$12.00 ➝ $13.00High
7/31/2020Piper SandlerBoost TargetOverweight$17.00 ➝ $23.00High
6/2/2020Deutsche Bank AktiengesellschaftLower TargetHold$12.00 ➝ $9.00High
5/7/2020Robert W. BairdLower TargetNeutral$16.00 ➝ $12.00Low
5/5/2020Cantor FitzgeraldLower TargetNeutral$17.00 ➝ $12.00High
5/5/2020Piper SandlerLower TargetOverweight$21.00 ➝ $17.00High
4/22/2020Jefferies Financial GroupLower TargetHold$14.00 ➝ $11.50High
4/20/2020Royal Bank of CanadaInitiated CoverageSector Perform$11.00Medium
4/13/2020SVB LeerinkInitiated CoverageMarket Perform$12.00High
3/27/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$16.00 ➝ $10.00High
3/26/2020SunTrust BanksLower TargetHold$14.00 ➝ $10.00High
3/18/2020Dougherty & CoUpgradeNeutral ➝ Buy$11.00High
1/8/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$18.00 ➝ $16.00Low
12/16/2019SunTrust BanksLower TargetHold$18.00 ➝ $14.00High
12/16/2019Morgan StanleyDowngradeEqual Weight ➝ Underweight$16.00 ➝ $12.00High
12/12/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$22.00 ➝ $17.00High
9/26/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$15.00Medium
9/17/2019Dougherty & CoUpgradeSell ➝ Neutral$1.00Low
8/29/2019KeyCorpUpgradeUnderweight ➝ Sector WeightMedium
8/23/2019Jefferies Financial GroupSet TargetHold$16.00Medium
8/23/2019Morgan StanleySet TargetHold$19.00 ➝ $16.00High
7/25/2019Dougherty & CoDowngradeNeutral ➝ SellHigh
5/29/2019Dougherty & CoDowngradeBuy ➝ NeutralHigh
4/25/2019SVB LeerinkUpgradeMarket Perform ➝ Outperform$19.00 ➝ $22.00Medium
1/11/2019Dougherty & CoUpgradeNeutral ➝ Buy$19.00High
12/6/2018Cantor FitzgeraldReiterated RatingBuy$23.00High
11/1/2018Morgan StanleyUpgradeUnderweight ➝ Equal Weight$12.00 ➝ $16.00Medium
10/31/2018KeyCorpLower TargetUnderweight ➝ Underweight$17.00 ➝ $16.00High
10/31/2018Cantor FitzgeraldLower TargetOverweight ➝ Overweight$26.00 ➝ $23.00High
(Data available from 3/30/2018 forward)

News Sentiment Rating

0.79 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/1/2022
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2022
  • 11 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2022
  • 10 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2022
  • 9 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2022
  • 6 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2023
  • 12 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/28/2023
  • 9 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/30/2023

Current Sentiment

  • 9 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

NextGen Healthcare logo
NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange. The company was founded by Sheldon Razin in 1974 and is headquartered in Irvine, CA.
Read More

Today's Range

Now: $17.12
Low: $16.98
High: $17.48

50 Day Range

MA: $18.01
Low: $16.69
High: $19.31

52 Week Range

Now: $17.12
Low: $16.13
High: $21.99

Volume

161,445 shs

Average Volume

453,537 shs

Market Capitalization

$1.13 billion

P/E Ratio

48.92

Dividend Yield

N/A

Beta

1.03

Frequently Asked Questions

What sell-side analysts currently cover shares of NextGen Healthcare?

The following Wall Street sell-side analysts have issued stock ratings on NextGen Healthcare in the last year: Guggenheim, Piper Sandler, StockNews.com, SVB Leerink LLC, TheStreet, and Truist Financial Co..
View the latest analyst ratings for NXGN.

What is the current price target for NextGen Healthcare?

4 Wall Street analysts have set twelve-month price targets for NextGen Healthcare in the last year. Their average twelve-month price target is $22.75, suggesting a possible upside of 32.9%. Guggenheim has the highest price target set, predicting NXGN will reach $26.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $20.00 for NextGen Healthcare in the next year.
View the latest price targets for NXGN.

What is the current consensus analyst rating for NextGen Healthcare?

NextGen Healthcare currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NXGN will outperform the market and that investors should add to their positions of NextGen Healthcare.
View the latest ratings for NXGN.

What other companies compete with NextGen Healthcare?

Other companies that are similar to NextGen Healthcare include LeMaitre Vascular, Protagonist Therapeutics, Alignment Healthcare, Geron and MoonLake Immunotherapeutics. Learn More about companies similar to NextGen Healthcare.

How do I contact NextGen Healthcare's investor relations team?

NextGen Healthcare's physical mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company's listed phone number is (949) 255-2600 and its investor relations email address is [email protected] The official website for NextGen Healthcare is www.nextgen.com. Learn More about contacing NextGen Healthcare investor relations.